Hormone control breakthrough from Ergopharm
Ergopharm proudly introduces 11-OXO™, the first selective inhibitor of 11b-hydroxysteroid
dehydrogenase type I reductase. Finally, cortisol control that delivers on
the promises.
Ergopharm has found the key to obtaining:
- Decreased body fat (especially visceral adipose tissue)
- Increased muscle density (hardness)
- Enhanced insulin sensitivity and glycogen deposition
- Increased strength
- Improved brain and CNS function
